bioMérieux ConnectionAn educational resource brought to you by bioMérieux, Inc.
An educational resource brought to you by bioMérieux, Inc.
By the bioMérieux Connection Editors In late 2013, the U.S. Food and Drug Administration (FDA) granted 510(k) de novo clearance to the first mass spectrometer for identifying disease-causing bacteria and yeast for clinical use in the U.S. market. The technology is called Matrix-Assisted Laser Desorption Ionization-Time of Flight mass spectrometry, or MALDI-TOF MS, and it uses a …
At Morton Plant Hospital BayCare Health System (MPMHC), we’ve learned the key to saving lives from sepsis without increasing antibiotic resistance is Procalcitonin (PCT) testing.
In 2015, the CRE strain of KPC (Klebsiella pneumonia carbapenemase) took the lives of seven patients at the National Institutes of Health Clinical Center near Washington, D.C. According to the CDC, the first reported CRE case occurred in a North Carolina Hospital in 2001, and since then, cases have been identified in 41 states.
Bacteria are constantly evolving, so even if we are able to develop an arsenal of new drugs, we will always need to stay one step ahead of the bugs. For that reason, we need to use diagnostics tests to help doctors prescribe antibiotics more accurately.
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
WASH, which stands for water, sanitation, and hygiene, are basic...